Julio C. Avalos-Sanchez

B, Argentina

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Innate immune memory - Trained immunity: Current concepts and clinical implications

Innate immune memory - Trained immunity: Current concepts and clinical implications

Journal: Medicina
Published: June 22, 2026

Identification of Predictive Biomarkers Based on Cytokine Profiles for Molecular Relapse After Treatment-Free Remission in Chronic Myeloid Leukemia Patients.

Identification of Predictive Biomarkers Based on Cytokine Profiles for Molecular Relapse After Treatment-Free Remission in Chronic Myeloid Leukemia Patients.

Journal: Cells
Published: March 12, 2026

Normal and emergency hematopoiesis: current concepts and clinical implications

Normal and emergency hematopoiesis: current concepts and clinical implications

Journal: Medicina
Published: August 12, 2025

In-depth characterization of NK cell markers from CML patients who discontinued tyrosine kinase inhibitor therapy.

In-depth characterization of NK cell markers from CML patients who discontinued tyrosine kinase inhibitor therapy.

Journal: Frontiers in immunology
Published: June 16, 2023

Elevated plasma levels of IL-6 and MCP-1 selectively identify CML patients who better sustain molecular remission after TKI withdrawal.

Elevated plasma levels of IL-6 and MCP-1 selectively identify CML patients who better sustain molecular remission after TKI withdrawal.

Journal: Journal of hematology & oncology
Published: January 16, 2023

Venetoclax-resistant CLL cells show a highly activated and proliferative phenotype.

Venetoclax-resistant CLL cells show a highly activated and proliferative phenotype.

Journal: Cancer immunology, immunotherapy : CII
Published: February 08, 2021

miRNome profiling of LSC-enriched CD34+CD38-CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.

miRNome profiling of LSC-enriched CD34+CD38-CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.

Journal: Frontiers in pharmacology
Published: September 30, 2020

Autologous T-cell activation fosters ABT-199 resistance in chronic lymphocytic leukemia: rationale for a combined therapy with SYK inhibitors and anti-CD20 monoclonal antibodies.

Autologous T-cell activation fosters ABT-199 resistance in chronic lymphocytic leukemia: rationale for a combined therapy with SYK inhibitors and anti-CD20 monoclonal antibodies.

Journal: Haematologica
Published: May 12, 2018

Revisiting the role of interleukin-8 in chronic lymphocytic leukemia.

Revisiting the role of interleukin-8 in chronic lymphocytic leukemia.

Journal: Scientific reports
Published: August 02, 2017

Sphingosine kinase 1 participates in the activation, proliferation and survival of chronic lymphocytic leukemia cells.

Sphingosine kinase 1 participates in the activation, proliferation and survival of chronic lymphocytic leukemia cells.

Journal: Haematologica
Published: April 01, 2017
Showing 1-10 of 10

Last Updated: 09/26/2026